Shares of IQVIA Holdings Inc. IQV rose 1.23% to $188.80 Friday, on what proved to be an all-around great trading session for ...

Shares of IQVIA Holdings Inc. IQV slipped 2.33% to $186.50 Thursday, on what proved to be an all-around grim trading session ...

RESEARCH TRIANGLE PARK, N.C., February 20, 2025--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the ...

BTIG analyst David Larsen downgraded Iqvia (IQV) to Neutral from Buy without a price target The firm says clinical research organization commentary from a large healthcare conference in January ...

IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, has published its 2024 ...

In a report released yesterday, Anne Samuel from J.P. Morgan maintained a Buy rating on IQVIA Holdings (IQV – Research Report), with a price ...

RESEARCH TRIANGLE PARK, N.C. – February 4, 2025 – IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, was named No. 1 in its ...

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the ...

IQVIA Holdings Inc. (IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services for the life sciences industry and is worth a market cap of $34 ...

IQVIA Holdings Inc. (NYSE:IQV), a global leader in advanced analytics, technology solutions, and clinical research services for the healthcare and life sciences industries, finds itself at a ...